Fu-Shun Yen

20PUBLICATIONS
24CO-AUTHORS
Molecular targetsSocio-economic developmentCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 03, 2026
Comparative risk of epilepsy with SGLT2 inhibitors versus incretin-based therapies in type 2 diabetes.

|Dec 09, 2025
Income-related inequities in the progression from gestational to type 2 diabetes: Findings from Taiwan's maternal and child health database.

Fu-Shun Yen, James Cheng-Chung Wei, Wan-Yi Lu

|Nov 03, 2025
SGLT2 inhibitors for primary prevention of macrovascular and major microvascular complications in type 2 diabetes: an island-wide cohort study.

Wan-Yin Cheng, Fu-Shun Yen, Yao-Min Hung

|Oct 24, 2025
Target trial emulation of DPP-4 Inhibitors in patients with T2DM for pulmonary tuberculosis: a nationwide observational data.

Yi-Geng Chen, James Cheng-Chung Wei, Fu-Shun Yen

|Oct 07, 2025
SGLT2 Inhibitors and Prevention of Cardiovascular Events in Diabetes Patients with and Without Hypertension: A Nationwide Cohort Study.

Fu-Shun Yen, James Cheng-Chung Wei, Yao-Min Hung

|Sep 27, 2025
Impact of Adding GLP-1 Receptor Agonists to Insulin Therapy on Cardiovascular and Microvascular Outcomes in Type 2 Diabetes: A Nationwide Cohort Study from Taiwan.

Fu-Shun Yen, James Cheng-Chung Wei, Chen-Yu Sung

Pageof 4

Frequent Collaborators

18 joint publications

Chii-Min Hwu

17 joint publications

Chih-Cheng Hsu

8 joint publications

James Cheng-Chung Wei

4 joint publications

Yao-Min Hung